LSL Pharma Group Inc. (TSXV:LSL)

Market Cap	41.01M
Revenue (ttm)	15.82M
Net Income (ttm)	-2.45M
Shares Out	115.53M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,000
Average Volume	51,266
Open	0.360
Previous Close	0.365
Day's Range	0.350 - 0.360
52-Week Range	0.310 - 0.550
Beta	n/a
RSI	43.40
Earnings Date	Feb 28, 2025

About LSL Pharma Group

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical and natural health products in Canada. It offers dietary supplements and vitamins in the tablet and capsule form; and niche sterile ophthalmic products in the form of ointments and drops for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Francois Roberge
• Employees: 114
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: LSL

Financial Performance

In 2023, LSL Pharma Group's revenue was 10.03 million, an increase of 22.08% compared to the previous year's 8.21 million. Losses were -8.47 million, 5.09% more than in 2022.